Remote Funded Healthcare Sector Momentum Trader — San Antonio, TX
San Antonio, TX
Maverick Trading
Healthcare-sector specialist book — biotech catalysts, pharma majors, devices, payers.
Central Time alignment, very low cost of living, and a strong financial-services labor market — a serious option for traders who want Texas without Austin or Dallas pricing.
A healthcare sector momentum trader at Maverick focuses on US healthcare equities — biotech catalysts, large pharma, medical devices, and the managed-care payer complex. The sector spans both highly volatile catalyst-driven small-caps and defensive large-cap names, which means a healthcare specialist runs two very different sub-strategies under one umbrella.
Trading from San Antonio, TX
San Antonio is anchored by USAA — one of the largest financial-services employers in the country — plus a growing cluster of insurance and asset-management operations. Central Time gives the metro clean alignment with US markets, and the cost of living is among the lowest of any major Texas city.
Local ecosystem: USAA headquarters; UTSA, Trinity University; growing tech-services sector.
Time zone: CT — the NYSE opens at 8:30am local for traders based in San Antonio.
What You'll Trade
Large pharma (JNJ, MRK, PFE, LLY) for stable trend trades and option liquidity, large biotech (AMGN, GILD, REGN) for fundamental-driven positioning, mid-cap biotech for catalyst trades around clinical data and FDA decisions, medical device names (ISRG, MDT) for steady momentum, and payers (UNH, ELV) for policy-driven moves.
Day-to-Day
- Morning: review the FDA calendar, clinical readout schedule, and overnight political/policy news affecting payers
- Track relative strength of healthcare sub-sectors versus XLV and the broader market
- Position into and out of catalyst events with defined risk — biotech binary events require options structures, not naked equity
- Manage steady-trend positions in large-caps with trailing stops
Risk Profile
Healthcare carries binary catalyst risk in biotech (one FDA decision moves a stock 40%), regulatory and political risk in payers and large pharma, and patent-cliff timing risk. Maverick limits biotech catalyst exposure to defined-risk structures and caps total sector concentration.
Who Succeeds in This Role
- Traders with a science or medical background — or who have done the work to understand it
- People who can read a clinical trial press release and assess the actual signal
- Candidates who already follow the FDA PDUFA calendar and major medical conferences
- Traders who can size catalyst trades for binary outcomes, not normal-distribution outcomes
Why This Role Exists at Maverick
Healthcare rewards domain expertise more than almost any other sector — the difference between a real clinical signal and noise isn't visible from price action alone. Maverick funds specialists who bring genuine sector knowledge, not generalists picking up healthcare names off a momentum screen.
What Maverick Offers
- Trade firm capital — no personal capital at risk
- 65%–90% profit split based on performance tier
- Performance-based capital scaling, no upper cap
- Professional training and mentorship from active traders
- Fully remote — trade from anywhere with reliable internet (US applicants)
- Monthly ACH payouts
- No challenge accounts, no evaluations, no monthly fees
About Maverick Trading
Maverick Trading is a proprietary trading firm founded in 1997. We allocate firm capital to disciplined traders and scale buying power based on performance. We are not a brokerage, we do not run challenge accounts, and we do not sell evaluations. We profit only when our traders profit.